NEW YORK (TheStreet) -- Robert W. Baird downgraded Theravance (THRX) to "hold" from "buy" and cited valuation after the recent split. The stock was down 1.52% to $26 in pre-market trading on Thursday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more. THRX data by YCharts STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.
